Skip to main content
logo
Daré Bioscience, Inc. (DARE)
NASDAQ: DARE · Real-Time Price · USD
1.280
+0.020 (1.59%)
At close: Jul 24, 2026, 4:00 PM EDT
1.261
-0.019 (-1.45%)
After-hours: Jul 24, 2026, 7:59 PM EDT

Daré Bioscience Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1.161.030.012.8110-
Revenue Growth
4366.48%10429.36%-99.65%-71.92%--
Gross Profit
1.160.730.012.8110-
Operating Income
-11.97-13.55-23.45-30.94-31.39-39.07
Net Income
-12.02-13.4-4.05-30.16-30.95-38.7
Earnings Per Share
-0.96-1.20-0.48-4.15-4.44-7.56
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
18.5224.7115.710.4834.6751.67
Total Debt
1.612.661.31.40.490.27
Net Cash (Debt)
16.9122.0614.49.0734.1851.4
Net Cash Growth
150.18%53.21%58.68%-73.46%-33.51%1213.79%
Net Cash Per Share
1.341.971.691.254.8510.09

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-9.94-9.895.47-38.86-18.09-28.76
Capital Expenditures
-0.23-0.39-0.57-0.63-0.06-0.01
Free Cash Flow
-10.16-10.274.9-39.49-18.15-28.78
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%71.29%100.00%100.00%100.00%-
Operating Margin
-1034.38%-1315.51%-239692.00%-1101.89%-313.86%-
Pretax Margin
-1041.32%-1300.66%-41430.90%-1074.17%-309.48%-
Profit Margin
-1038.77%-1300.66%-41430.90%-1074.17%-309.48%-
FCF Margin
-878.30%-997.01%50087.00%-1406.26%-181.52%-

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
P/FCF Ratio
--5.54---
PS Ratio
16.5727.162774.4511.017.04-